Corrado Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,413
Closed -$165K 108
2024
Q3
$165K Sell
10,413
-89
-0.8% -$1.4K 0.1% 101
2024
Q2
$161K Sell
10,502
-1,134
-10% -$17.2K 0.1% 106
2024
Q1
$191K Buy
11,636
+19
+0.2% +$300 0.13% 103
2023
Q4
$170K Sell
11,617
-3,908
-25% -$54.5K 0.14% 75
2023
Q3
$224K Buy
15,525
+29
+0.2% +$452 0.15% 104
2023
Q2
$254K Buy
15,496
+27
+0.2% +$440 0.18% 84
2023
Q1
$258K Buy
15,469
+9
+0.1% +$145 0.17% 105
2022
Q4
$239K Buy
+15,460
New +$239K 0.17% 113
2022
Q3
Sell
-15,460
Closed -$254K 105
2022
Q2
$254K Hold
15,460
0.18% 101
2022
Q1
$310K Buy
+15,460
New +$321K 0.19% 92

Other funds holding BMEZ

Corrado Advisors's BMEZ Position: Q4 2024 in Review

Corrado Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2024, closing a stake of 10,413 shares — an estimated $165K sold.

Corrado Advisors first reported a position in BMEZ in Q1 2022 and held it in 10 quarters. The position peaked at $310K in Q1 2022. 103 funds tracked by Wall St. Rank hold BMEZ as of Q4 2024.

  • Corrado Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q4 2024 after selling out during the quarter.
  • Corrado Advisors sold 10,413 BlackRock Health Sciences Trust II shares in Q4 2024, an estimated $165K.
  • Corrado Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2022 and held it in 10 quarters.
  • Corrado Advisors's BlackRock Health Sciences Trust II position peaked at $310K in Q1 2022.
  • 103 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2024.

Based on Corrado Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.